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ABSTRACT
Background: It is a well-known fact that IgE is a key
substance that induces an allergic reaction in extravas-
cular tissue. However, it remains to be elucidated how
IgE in the circulating blood transfers to the site of the
allergic reaction in the extravascular tissue. In the
present paper, rat IgE passage through cultured rat
aortic endothelial cells (RAEC) was first examined
using a dual-chamber system. Second, we examined
the effects of histamine, which is thought to affect
endothelial permeability, on IgE passage through the
RAEC in comparison with the effects of albumin and
IgG2a.
Methods: The permeability constant (PC) was used to
evaluate the degree of IgE passage through the RAEC.
Results: The value of the PC for rat IgE (0.58 ± 0.11
× 10–5 cm/s) was lower than that for IgG2a and
albumin (0.88 ± 0.28 × 10–5 and 0.93 ± 0.26 ×
10–5 cm/s, respectively) under conditions of non-expo-
sure to histamine. In contrast, the PC of rat IgE was
significantly increased by exposure to histamine 
(10–10 mol/L) at 12 h after exposure. However, the PC
for IgG2a and albumin were not significantly
increased following exposure to histamine. The
enhancement by histamine of IgE passage through the
RAEC was not inhibited by diphenhydramine, a hista-
mine H1 receptor antagonist, but were inhibited by
cimetidine, a histamine H2 receptor antagonist.
Conclusions: On the basis of results from the present
study, histamine, acting via H2 receptors, enhances 
the permeability of rat IgE across the RAEC mono-
layer. The increased permeability of endothelial cells
induced by histamine may contribute greatly to the
transfer of IgE from circulating blood to extravascular
tissue.
Key words: IgE, endothelial cells, histamine,
permeability.
INTRODUCTION
The allergic reaction in tissues is known to be related to
several factors, including allergen-specific IgE, IgE target
cells, allergen and inflammatory cells. Inflammatory cells,
such as eosinophils, in the circulation are also known 
to accumulate at the site of allergic inflammation in 
extravascular tissue. It has been thought that IgE, a key
substance in the allergic reaction in extravascular tissues,
is produced in the tissue and/or distributed from the cir-
culating blood to the tissue. However, it remains to be
elucidated how IgE in the circulating blood transfers to
the extravascular tissue and acts in the process of an
allergic reaction. On the basis of clinical data, elevated
IgE in the circulating blood of patients with allergic dis-
eases cannot be regarded as a pathophysiological sign
of allergy1 and it is thought that the IgE level in the circu-
lating blood does not always reflect the amount of IgE in
the tissue. Therefore, we need to determine the regulatory
mechanism by which IgE passes through the vascular wall
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to the tissue. In addition, there is one report that mouse or
human mast cells can secrete vascular permeability
factor/vascular endothelial growth factor (VPF/VEGF)
and that this secretion is enhanced via activation of
IgE receptors.2 It is suggested from this report that the
passage of IgE through the vascular wall to the tissue may
be regulated by biological substances from the extravas-
cular cells, such as mast cells. In the present study, we
investigated both IgE passage through cultured endothe-
lial cells and the effect of histamine on IgE passage in
comparison with the passage of albumin and IgG2a.
METHODS
Animals
Wistar-strain male rats, weighing 250–300 g, were used.
Rats were purchased from Kyudo (Kumamoto, Japan).
Animal care and management
We followed the Standards Relating to the Care and
Management of Experimental Animals (Notification 
No. 6, 27 March 1980, from the Prime Minister’s Office,
Tokyo, Japan) for the care and use of animals, together
with the Guide for Animal Experiments issued by the
University of the Ryukyus. All animal studies were
reviewed and approved by the Animal Care Committee
at the University of the Ryukyus.
Reagents
2,4-Dinitrobenzene sulfonic acid sodium salt was
purchased from Tokyo Kasei (Tokyo, Japan). Nutrient
mixture F-12 HAM, Kaighn’s modification (HAM’s 
F-12K), collagenase type XI (cell culture grade) and 2,2′-
azino-di-[3-ethyl-benzthiazoline-6-sulfonic acid] (ABTS)
were purchased from Sigma Chemical Co. (St Louis,
MO, USA). Tween-20 and gelatin fine powder were
obtained from Nacalai Tesque (Kyoto, Japan) and hydro-
gen peroxide was obtained from Santoku Chemical
(Miyagi, Japan). Aminohexanoyl-biotin-N-hydroxysuccin-
imide, peroxidase-conjugated streptavidin, rat myeloma
IgG2a and monoclonal mouse antirat IgG2a were
obtained from Zymed Laboratories (San Francisco, CA,
USA). A Falcon cell culture insert (diameter 6 mm; pore
size 3 µm; pore density 8.0 × 105 /cm2) and its compan-
ion plate were purchased from Becton Dickinson
(Franklin Lakes, NJ, USA). Fetal bovine serum (FBS) was
obtained from Sanko Junyaku (Fukuoka, Japan).
Peroxidase (POD)-conjugated goat antirabbit IgG was
purchased from BioRad Laboratories (Richmond, CA,
USA). Rabbit antirat IgG rabbit antirat albumin was
purchased from Inter-cell Technologies (New Jersey, NJ,
USA). Type I collagen from the rat tail was obtained from
Collaborative Biomedical Products (Bedford, MA, USA).
The POD-conjugated sheep antirat albumin was pur-
chased from Cappel Products, (ICN Pharmaceuticals,
West Chester, PA, USA). Endothelial cell growth sup-
plement (ECGS) and Dil-labeled acetylated low-density
lipoprotein (DiI-Ac-LDL) were obtained from Harbor Bio-
Products (Norwood, MA, USA). Unless otherwise stated,
all other chemicals were of reagent grade.
Isolation of rat aortic endothelial cells using a
primary explant technique
Isolation of rat aortic endothelial cells was performed
according to the method of MacGuire and Orkin.3 The
full length of the thoracic aorta was aseptically removed
from the thoracic cavity of a Wistar rat and rinsed in
HAM’s F-12K. The vessel was gently cleaned to exclude
periadventitial fat and connective tissue and was then cut
into flat segments measuring approximately 5 × 5 mm.
These flat aortic segments were placed endothelial-side
down on a dish coated with type I collagen and 1 mL
culture medium (HAM’s F-12K containing 10% 
FBS, 50 µg/mL crude endothelial cell growth factor, 
100 µg/mL penicillin and 100 µg/mL streptomycin) was
added. Explants were incubated overnight in a humidified
incubator (Astec, Fukuoka, Japan) at 37°C in a 95%
air/5% CO2 atmosphere and, 24 h later, 1 mL culture
medium was added to the dish. Aortic explants were
removed after 6–7 days according to their degree of 
outgrowth. Passaged cells from the tissue culture dish
exhibited a ‘cobblestone’ morphology. A solution of
0.25% collagenase in serum-free medium was used to
abrade the cells from the collagen-coated dish. These
cells were then routinely subcultured for up to 4 passages
with 0.25% collagenase. The cells obtained were identi-
fied as endothelial cells from their uptake of DiI-Acl-LDL.
They were subsequently incubated in the presence of 
10 µg/mL DiI-Ac-LDL for 4 h at 37°C. Finally, the
medium was removed and cells were washed three 
times with phosphate-buffered saline (PBS). Low-density
lipoprotein particles were visualized by fluorescence
microscopy (Nikon, Tokyo, Japan) with filters adjusted for
rhodamine fluorescence.
Chamber preparation
Polyethylene terephthalate track-etched membranes of the
Falcon cell culture insert (upper chamber) were coated with
type I collagen. These upper chambers were placed into
each well of a 24-well plate (lower chamber). Cells were
removed from the tissue flask by treatment with 0.25%
collagenase and centrifuged at 430 g for 5 min. The cell
pellet was resuspended in complete culture medium and
0.43 mL, containing 1 × 105 cells, was seeded onto each
collagen-coated membrane. Experiments were performed
3 days after seeding. Monolayer confluence on the mem-
branes was evaluated by light microscopy.
Preparation of monoclonal dinitrophenyl-
specific rat IgE and rat albumin
The procedure used for the preparation of monoclonal
dinitrophenyl (DNP)-specific rat IgE was as described
previously.4 Rat albumin was purified from the serum of
normal rats as follows. Normal rat serum was precipi-
tated with ammonium sulfate at a 50% saturation at 
4°C, dissolved in PBS and extensively dialyzed against 
5 mmol/L phosphate buffer (PB), pH 7.0. Rat albumin
was further purified by means of ion-exchange chro-
matography using DEAE-Sephacel (Amersham Pharmacia
Biotech, Uppsala, Sweden). The adsorbed proteins were
eluted with 0.1 mol/L PB, pH 5.8. Two protein peaks
were observed in the ion-exchange chromatography
profile. The second protein peak was a 67 kDa band on
sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis (SDS-PAGE) and it reacted with rabbit antirat
albumin on western blot analysis.
IgE-capture ELISA to estimate monoclonal
DNP-specific rat IgE
The IgE-capture ELISA to estimate rat IgE antibodies to
DNP–Ascaris (As) was performed as described previ-
ously.4 The ELISA plate was coated with 1 µg/mL rabbit
antibodies to monoclonal DNP-specific rat IgE. After
blocking with Dulbecco’s PBS containing 2% gelatin for 
1 h at room temperature, the wells were incubated with
monoclonal DNP-specific rat IgE or samples collected
from the upper and lower chambers. Following washing,
the wells were incubated with 1 µg/mL biotinylated 
DNP-As in 2% gelatin–PBS containing 0.05% Tween 20
(PBST) for 30 min at room temperature. After further
washing, the wells were incubated with a 1/3000 dilution
of POD-conjugated streptavidin in 2% gelatin-PBST for
30 min at room temperature. Substrate solution (ABTS)
was then added to each well, and spectrophotometric
readings were made using λ1 = 415 nm and λ2 = 492
nm wavelength filters of a dual wavelength microplate
photometer (MTP-22; Corona Electric, Ibaraki, Japan).
ELISA to estimate rat albumin
The ELISA plate was coated with 1 µg/mL rabbit antirat
albumin. After blocking with Dulbecco’s PBS containing
1% skimmed milk for 1 h at room temperature, the wells
were incubated with rat albumin or samples collected
from the upper and lower chambers. Following washing,
the wells were incubated with a 1/3000 dilution of POD-
conjugated sheep antirat albumin in PBST for 1 h at room
temperature. Other details of the ELISA procedure were
as described for the IgE-capture ELISA to estimate mono-
clonal DNP-specific rat IgE.
ELISA to estimate rat IgG2a
The ELISA plate was coated with 1 µg/mL monoclonal
mouse antirat IgG2a. After blocking with Dulbecco’s PBS
containing 1% skimmed milk for 1 h at room tempera-
ture, the wells were incubated with rat myeloma IgG2a or
samples collected from the upper and lower chambers.
Following washing, the wells were incubated with a
1/1000 dilution of polyclonal rabbit antirat IgG in PBST
for 1 h at room temperature. After further washing, the
wells were incubated with a 1/3000 dilution of POD-
conjugated goat antirabbit IgG in PBST for 1 h at room
temperature. Other details of the ELISA procedure were
as described for IgE-capture ELISA to estimate mono-
clonal DNP-specific rat IgE.
Experimental protocol for IgE passage
through the endothelial cell monolayer
A 0.43 mL aliquot of serum-free medium containing
monoclonal DNP-specific rat IgE, rat serum albumin or
rat myeloma IgG2a was added to the upper chamber
and 1 mL serum-free medium was added to the lower
chamber. Samples (30 µL) from the upper chamber were
taken out and an equal volume of medium was added at
different time points. Samples (1 mL) from the lower
chamber were taken out and an equal volume of medium
was added to the lower chamber at different time points.
The IgE in the medium of the upper and lower chambers
was determined by IgE-capture ELISA and albumin and
IgG2a were estimated by ELISA.
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Effect of histamine on IgE passage through
endothelial cells
Serum-free medium containing different concentrations
of histamine (10–13 to 10–9 mol/L) was added to the
upper chamber, which contained a rat endothelial cell
monolayer. Unless otherwise stated, the reaction time
was 24 h. The degree of IgE passage through the
endothelial cells was calculated after the endothelial cells
were exposed to histamine.
Effect of histamine antagonists on IgE
passage through endothelial cells exposed to
histamine
Serum-free medium containing histamine and a hista-
mine antagonist or anti-allergic drugs at different
concentrations was added to the upper chamber, which
contained a rat endothelial cell monolayer. The reaction
time was 24 h. The degree of IgE passage through
endothelial cells was calculated after washing the endo-
thelial cell monolayer on the membrane with serum-free
medium.
Data analysis
The degree of IgE passage through endothelial cells was
expressed as a permeability constant (PC) according to
the method of Cooper et al.5 The clearance volume of
IgE at different time points (VIgEt), which indicates the
volume of the upper chamber cleared of IgE through
the endothelial cell monolayer, was calculated by
summing the incremental clearance volumes up to that
time point:
VIgEt = ∑(VLi·∆[L]i/[U]i)
where VLi is the volume of the lower chamber at different
time points, ∆[L]i is the increase in IgE concentration
between time points and [U]i is the concentration of IgE
in the upper chamber at different time points. The change
in VIgE over time (dVIgE/dt), equal to the clearance rate 
in µL/min, was determined by weighted least-squares
non-linear regression for the reaction time. Furthermore,
if:
(PS·(VU + VL)/(VU·VL))·t < 0.1
then, with an error of < 5%, dVIgE/dt = PS, where P is the
PC, S is the surface area, VU is the volume of the upper
chamber and VL is the volume of the lower chamber.
Statistical analysis
Statistical analysis was performed by unpaired Student’s 
t-test for between-group comparisons. Data are expressed
as the mean±SD. When P < 0.05 was obtained, the
means were considered to be significantly different.
RESULTS
Correlation of clearance volume and reaction
time of IgE, albumin and IgG2a
Three continuous lines formed the weighted least-squares
regression curves for the experimental period in the case
of IgE. The slope of each line indicated the clearance 
rate for the experimental period. Therefore, the PC of IgE
across the endothelial cell monolayer was calculated on
the basis of its clearance rate. In contrast, in the case of 
5 µg/mL IgE, which was added to the upper chamber, the
continuous line did not pass over the origin and the value
of the clearance rate was lower than in other cases.
However, in the case of the addition of 10 and 20 µg/mL
IgE to the upper chamber, both lines passed over near the
point of origin. The value of the clearance rate in the case
of 10 µg/mL IgE added to the upper chamber was larger
than that in the case of 20 µg/mL IgE. From these results,
10 µg/mL was selected as the proper concentration of
IgE in the medium to be added to the upper chamber in
the present study (Fig. 1a). The PC of IgE across the
endothelial cell monolayer was approximately 0.58 ×
10–5 cm/s under these conditions. In the case of the addi-
tion of 5, 10 and 20 µg/mL IgG2a or albumin to the
upper chamber, each line passed over near the point of
origin and the values for the clearance rate were almost
the same at different concentrations (Fig. 1b,c). Con-
sequently, 10 µg/mL IgG2a and albumin was used in the
present study.
Permeability constant of rat IgE, IgG2a and
albumin across the endothelial cell monolayer
The PC of rat IgE was smaller than that of IgG2a or
albumin (P < 0.05). In contrast, no significant differ-
ences in PC were noted between rat IgG2a and albumin
(Fig. 2).
Effect of histamine on the PC of IgE, IgG2a
and albumin across endothelial cells
The PC of IgE across the endothelial cell monolayer
exposed to histamine (above 10–11 mol/L) was signifi-
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cantly increased compared with the PC of IgE across the
endothelial cell monolayer not exposed to histamine 
(Fig. 3a). At 10–10 mol/L, histamine produced the great-
est enhancement of the PC of rat IgE. The kinetics of the
enhancing effect of histamine (10–10 mol/L) on the PC of
rat IgE were examined over the time range 3–24 h. A sig-
nificant increase in PC following exposure to histamine
appeared after 12 h compared with cells not exposed to
histamine and reached to its peak (approximately 1.5 ×
10–5 cm/s) after 24 h (Fig. 3b). In contrast, no significant
differences were observed between PC of rat IgG2a and
albumin in cell monolayers exposed or not exposed to
histamine (Fig. 4).
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Fig. 1 Clearance volume–reaction time curves for rat (a) IgE,
(b) IgG2a and (c) albumin. A single passage assay was
performed in serum-free medium (HAM’s F-12K). Different
concentrations of IgE, IgG2a and albumin (0.43 mL) were
added to the upper chamber at the start of the assay: (), 
5 µg/mL; (), 10 µg/mL; (), 20 µg/mL.The concentrations
of IgE, IgG2a and albumin in the upper and lower chambers
were determined at different time points and the clearance
volume was calculated, as described in Methods.
Fig. 2 Permeability constant (PC) of rat IgE, IgG2a and
albumin across rat endothelial cells.The PC of rat IgE, IgG2a
and albumin across the cells was determined following incuba-
tion of cells with serum-free medium for 24 h and was
calculated as described in Methods. Data are the mean±SD
(n = 10). *P < 0.05 compared with IgE.
Effect of histamine antagonists on the PC of IgE
across endothelial cells exposed to histamine
At concentrations of 10–10 to 10–6 mol/L, cimetidine, a
histamine H2 receptor antagonist, lowered the increased
PC of IgE across endothelial cells following exposure to
histamine (P < 0.01). In contrast, diphenhydramine, a
histamine H1 receptor antagonist, did not exert any sig-
nificant effect on the PC of IgE at the indicated
concentrations (Fig. 5).
DISCUSSION
The PC of rat IgE (0.58 ± 0.11 × 10–5 cm/s) was smaller
than that of IgG2a (0.88 ± 0.28 × 10–5 cm/s) and
albumin (0.93 ± 0.26 × 10–5 cm/s). It was, however,
indicated that the permeability of rat IgE across rat aortic
endothelial cells (RAEC) was enhanced following the
exposure of the cells to histamine. In contrast, the per-
meability of IgG2a and albumin was not enhanced
following exposure of RAEC to histamine. Morphological
changes in RAEC were not observed after exposure to his-
tamine. On the basis of these results, we suggest that the
passage of IgE through endothelial cells was more sus-
ceptible to enhancment by histamine than was the
passage of either IgG2a or albumin. Histamine is a pre-
formed mediator of mast cells and is released following
degranulation of mast cells induced by stimuli such as
exposure to allergen.6 Therefore, from the results
obtained in the present study, an acceptable interpreta-
tion is that the passage of IgE through the vascular wall
via endothelial cells to extravascular tissue may be
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Fig. 3 Effect of histamine on the permeability of rat IgE
across rat endothelial cells. Histamine () was applied to the
endothelial cell monolayer in the upper chamber at different
concentrations, and the permeability of the monolayer of rat
IgE was examined (a). The time-course of the increased perme-
ability of IgE across the endothelial monolayer after exposed to
10–10 mol/L histamine was also examined (b). The permeability
constant (PC) of IgE across the endothelial cells was calculated
as described in Methods. Data are the mean±SD (n = 3). 
*P < 0.05 compared with serum-free medium ().
Fig. 4 Comparison of permeability constants (PC) of rat
endothelial cells exposed to histamine for rat IgG2a and
albumin. Histamine (10–10 mol/L; ) was applied to the
endothelial cell monolayer in the upper chamber for 24 h. The
PC of the monolayer for rat IgG2a and albumin was calculated
as described in Methods. Data are the mean±SD (n = 5). 
(), serum-free medium
enhanced by histamine released from mast cells at the
site of the allergic reaction.
Boesiger et al. have reported that human and mouse
mast cells secrete VPF/VEGF and that secretion of
VPF/VEGF was enhanced after IgE-dependent upregula-
tion of FcεRI expression, irrespective of exposure to
allergen.2 It has been shown that VPF/VEGF can enhance
vascular permeability and induce proliferation of vascu-
lar endothelial cells.7–10 Both tumor necrosis factor-α and
interluekin-6 have an enhancing effect on endothelial
permeability and are newly synthesized mediators of mast
cells.11–13 It is suggested from the results of the present
study and from results of other published studies that the
permeable IgE itself, due to release of chemical media-
tors or cytokines from mast cells, is an enhancer of IgE
passage through the endothelial cells to the tissue.
The enhancement by histamine of the passage of IgE
through endothelial cells was not inhibited by diphenhy-
dramine, a H1 receptor antagonist, but was blocked by
cimetidine, a H2 receptor antagonist. These findings
suggest that the aforementioned effects of histamine on
endothelial cells are mediated via activation of H2 and
not H1 receptors.
The mechanism responsible for the effects of hista-
mine, following stimulation of histamine receptors, on the
passage of IgE through endothelial cells remains to be
clarified. It is generally accepted that vascular endothelial
cells represent a permselective barrier for the transport of
a broad variety of molecules from the circulating blood
to the interstitial fluid. Under physiological conditions, a
highly controlled mechanism should be related to the
barrier function of endothelial cells. With regard to the
permeability of serum albumin, it has been reported that
the endothelial albumin-binding protein is involved in the
specific binding of albumin and is followed by transport
of albumin.14–16 Histamine was more effective in enhanc-
ing the permeability of IgE than IgG2a and albumin.
Therefore, it is inferred that there is a specific mechanism
for the passage of IgE through the endothelial cells via an
alternative cell-surface protein with a binding affinity for
IgE. The cell-surface protein galectin-3 has an affinity for
IgE and is located on the membrane of endothelial
cells;17,18 the expression of galectin-3 may be associated
with the activation of signal transudation in endothelial
cells via histamine H2 receptors.
We are studying whether any biological substances
derived from mast cell other than histamine can or
cannot enhance the permeability of IgE through RAEC.
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